Related Experiment Video
Updated: Apr 5, 2026
07:42
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
Published on: December 16, 2022
3.9K
[How to care for elderly patients with cognitive impairment?]
1Pôle de gérontologie clinique, hôpital Xavier-Arnozan, CHU de Bordeaux, 33604 Pessac cedex, France.
Summary
Mild cognitive impairment (MCI) is common in aging and linked to vascular risks. Comprehensive geriatric assessment aids diagnosis and management, improving daily living for elderly patients, especially those with cancer.
Area of Science:
- Geriatric Medicine
- Neurology
- Public Health
Context:
- Aging population and increased life expectancy lead to a higher incidence of dementia.
- Elderly cancer patients face unique challenges, including cognitive impairment impacting treatment adherence.
- Vascular risk factors in adulthood are strongly associated with mild cognitive impairment.
Purpose:
- To highlight the prevalence and impact of cognitive impairment in aging populations, particularly in elderly cancer patients.
- To emphasize the role of comprehensive geriatric assessment in diagnosing and managing cognitive decline.
- To outline strategies for supporting elderly individuals with cognitive impairment, including home care and rehabilitation.
Summary:
- Mild cognitive impairment (MCI), characterized by memory and executive function deficits, is prevalent in aging and linked to vascular risks.
- Cognitive impairment significantly affects elderly cancer patients' understanding of diagnosis, treatment, and medication management.
- Comprehensive geriatric assessment is crucial for identifying MCI and its impact on activities of daily living (ADL) and instrumental activities of daily living (IADL).
Impact:
- Early diagnosis and intervention through geriatric assessment can improve functional independence and quality of life for aging individuals.
- Integrated care approaches, including home care, social support, and rehabilitation, are essential for managing cognitive impairment in the elderly.
- Specialized case management, such as MAIA in France, facilitates better coordination between healthcare providers and home carers for Alzheimer's patients.
Keywords:
Cognitive troublesDependancyOncogeriatricsOncogériatriePersonnes âgéesPerte d’autonomieTroubles cognitifsMore Related Videos
Related Concept Videos
01:30Cognitive Development During Adulthood
1.2K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.2K
01:15Drug Dosing: Geriatric Patients
357
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
357
01:30Dementia
709
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
709
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
869
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
869
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
325
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
325